Raymond James & Associates’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.56M | Buy |
76,232
+11,288
| +17% | +$824K | ﹤0.01% | 1590 |
|
|
2024
Q2 | $4.35M | Buy |
64,944
+2,943
| +5% | +$197K | ﹤0.01% | 1679 |
|
|
2024
Q1 | $1.68M | Buy |
62,001
+20,885
| +51% | +$567K | ﹤0.01% | 2264 |
|
|
2023
Q4 | $1.27M | Sell |
41,116
-3,098
| -7% | -$96K | ﹤0.01% | 2365 |
|
|
2023
Q3 | $1.12M | Buy |
44,214
+12,573
| +40% | +$317K | ﹤0.01% | 2378 |
|
|
2023
Q2 | $668K | Sell |
31,641
-692
| -2% | -$14.6K | ﹤0.01% | 2723 |
|
|
2023
Q1 | $551K | Buy |
32,333
+4,542
| +16% | +$77.4K | ﹤0.01% | 2840 |
|
|
2022
Q4 | $555K | Buy |
27,791
+6,131
| +28% | +$122K | ﹤0.01% | 2814 |
|
|
2022
Q3 | $467K | Buy |
21,660
+850
| +4% | +$18.3K | ﹤0.01% | 2900 |
|
|
2022
Q2 | $410K | Sell |
20,810
-77
| -0.4% | -$1.52K | ﹤0.01% | 3018 |
|
|
2022
Q1 | $491K | Sell |
20,887
-284
| -1% | -$6.68K | ﹤0.01% | 3072 |
|
|
2021
Q4 | $577K | Sell |
21,171
-791
| -4% | -$21.6K | ﹤0.01% | 2972 |
|
|
2021
Q3 | $605K | Sell |
21,962
-1,072
| -5% | -$29.5K | ﹤0.01% | 2916 |
|
|
2021
Q2 | $656K | Buy |
23,034
+742
| +3% | +$21.1K | ﹤0.01% | 2878 |
|
|
2021
Q1 | $759K | Sell |
22,292
-576
| -3% | -$19.6K | ﹤0.01% | 2689 |
|
|
2020
Q4 | $761K | Sell |
22,868
-651
| -3% | -$21.7K | ﹤0.01% | 2513 |
|
|
2020
Q3 | $756K | Buy |
23,519
+519
| +2% | +$16.7K | ﹤0.01% | 2340 |
|
|
2020
Q2 | $633K | Buy |
23,000
+5,869
| +34% | +$162K | ﹤0.01% | 2433 |
|
|
2020
Q1 | $275K | Sell |
17,131
-178,518
| -91% | -$2.87M | ﹤0.01% | 2818 |
|
|
2019
Q4 | $4.67M | Buy |
195,649
+18,419
| +10% | +$440K | 0.01% | 1295 |
|
|
2019
Q3 | $3.13M | Buy |
177,230
+34,933
| +25% | +$616K | ﹤0.01% | 1522 |
|
|
2019
Q2 | $3.64M | Buy |
142,297
+39,976
| +39% | +$1.02M | 0.01% | 1423 |
|
|
2019
Q1 | $2.97M | Buy |
102,321
+44,564
| +77% | +$1.3M | ﹤0.01% | 1514 |
|
|
2018
Q4 | $758K | Buy |
57,757
+29,150
| +102% | +$383K | ﹤0.01% | 2257 |
|
|
2018
Q3 | $578K | Buy |
+28,607
| New | +$578K | ﹤0.01% | 2603 |
|